Astrazeneca

FromAstraZeneca ([email protected])
Subject (45)Dato-DXd approved in US for HR+ breast cancer
Preheader (47)͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Typography
Arial
Colors
Text Analysis
Body Words244
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px752 px
X-Spam Score0.9
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeAfternoon

Dato-DXd approved in US for HR+ breast cancer

͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Dato-DXd approved in US for HR+ breast cancer